Effects of ZEB1 on regulating osteosarcoma cells via NF-κB/iNOS

X-M Xu1, W Liu, Z-H Cao

  • 1Hand and Foot Bone Surgery, Weifang People's Hospital, Weifang, Shandong, China. meixiuliu016@163.com.

Abstract

Insights

Inhibiting Zinc finger E-box binding homeobox 1 (ZEB1) protein can reduce osteosarcoma cell growth and spread. This occurs by decreasing the NF-kB/iNOS signaling pathway, promoting cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma is a common malignant bone tumor with poor prognosis due to invasion, metastasis, and recurrence.
  • The complex pathogenesis of osteosarcoma is not fully understood, necessitating the identification of effective molecular targets.
  • Zinc finger E-box binding homeobox 1 (ZEB1) is implicated in tumor development and is upregulated in osteosarcoma, but its regulatory mechanism remains unclear.

Purpose of the Study:

  • To investigate the role of ZEB1 in osteosarcoma progression.
  • To elucidate the regulatory mechanism of ZEB1 in osteosarcoma.
  • To determine if targeting ZEB1 can improve osteosarcoma treatment efficacy.

Main Methods:

  • Osteosarcoma MG-63 cells were transfected with ZEB1 siRNA.
  • ZEB1 mRNA and protein expression were assessed using real-time PCR and Western blot.
  • Cell proliferation (MTT assay), invasion, apoptosis (caspase-3 activity), and NF-kB/iNOS protein levels were evaluated.

Main Results:

  • Transfection with ZEB1 siRNA inhibited MG-63 cell proliferation and invasion.
  • ZEB1 knockdown led to increased caspase-3 activity, indicating enhanced apoptosis.
  • Down-regulation of NF-kB and iNOS proteins was observed in ZEB1-silenced cells.

Conclusions:

  • Inhibition of ZEB1 facilitates osteosarcoma cell apoptosis.
  • Targeting ZEB1 suppresses osteosarcoma cell proliferation and invasion.
  • ZEB1 may exert its effects by down-regulating the NF-kB/iNOS signaling pathway.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...